vexibinol

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namevexibinol
Drug Alias Name4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-[2,4-bis(acetyloxy)phenyl]-2,3-dihydro-6-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsUlcerAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuraray Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuraray Co Ltd
Active IndicationsN/A
Inactive IndicationsUlcerAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A